Offer - Urjas Oil for just ₹ 1 X
Moxifloxacin + Tobramycin is an allopathic medicine The correct dosage of Moxifloxacin + Tobramycin depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Moxifloxacin + Tobramycin is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Moxifloxacin + Tobramycin is used -
Severe
Moderate
Mild
Common
Is the use of Moxifloxacin + Tobramycin safe for pregnant women?
Moxifloxacin + Tobramycin should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Moxifloxacin + Tobramycin safe during breastfeeding?
Breastfeeding women may feel side effects of Moxifloxacin + Tobramycin. If you see any side effects, stop taking Moxifloxacin + Tobramycin immediately and talk to your doctor. Take Moxifloxacin + Tobramycin again, only after your doctor's advice.
What is the effect of Moxifloxacin + Tobramycin on the Kidneys?
Moxifloxacin + Tobramycin rarely affects the kidneys.
What is the effect of Moxifloxacin + Tobramycin on the Liver?
Using Moxifloxacin + Tobramycin does not have any harmful effects on the liver.
What is the effect of Moxifloxacin + Tobramycin on the Heart?
Using Moxifloxacin + Tobramycin does not have any harmful effects on the heart.
Moxifloxacin + Tobramycin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Moxifloxacin + Tobramycin unless your doctor advises you to do so -
Is this Moxifloxacin + Tobramycin habit forming or addictive?
Moxifloxacin + Tobramycin is not addictive in nature.
Interaction between Food and Moxifloxacin + Tobramycin
Taking Moxifloxacin + Tobramycin with food does not cause any problems.
Interaction between Alcohol and Moxifloxacin + Tobramycin
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Moxifloxacin + Tobramycin.
Yes, Moxifloxacin + Tobramycin is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as dizziness, nausea, and vomiting. If you experience above-mentioned side effects after taking this medicine then inform your doctor and follow his/her instructions.
No, Moxifloxacin + Tobramycin does not cover strains of Pseudomonas aeruginosa. It is generally found to be resistant to Moxifloxacin + Tobramycin. Hence other antibiotics which are active against Pseudomonas aeruginosa should be used.
Moxifloxacin + Tobramycin is a brand name of moxifloxacin and it comes in form of a tablet, infusion, eye drops, and eye ointment. It is a prescription drug that belongs to the class of drug known as fluoroquinolones. It is a broad spectrum antibiotic which is used for the treatment of bacterial infections such as skin infections, eye infections, intra-abdominal infections, chronic bronchitis, community-acquired pneumonia, and sinusitis.
No, Moxifloxacin + Tobramycin does not cover MRSA (methicillin-resistant Staphylococcus aureus) infections. It is only effective against methicillin-susceptible strains only.
Yes, Moxifloxacin + Tobramycin covers anaerobes. It is effective against some of the anaerobic bacteria such as Bacteroides fragilis, Bacteroides thetaiotaomicron, Clostridium perfringens, and Peptostreptococcus species.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tobramycin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-141